期刊文献+

尿L-FABP在预测急性肾损伤预后中的意义 被引量:1

Urinary liver-type fatty acid-binding protein as a prognostic biomarker in patients with acute kidney injury
下载PDF
导出
摘要 目的 观察住院急性肾损伤(AKI)患者尿肝脏型脂肪酸结合蛋白(L-FABP)的水平,分析其对肾脏替代治疗(RRT)及住院死亡的预测能力.方法 前瞻性收集经肾内科医师会诊确诊AKI患者103例,留取会诊时患者的血尿标本,检测其血尿肌酐及尿L-FABP水平.运用ROC曲线评估尿L-FABP预测AKI患者预后的准确性.结果 ①103例患者中,50例接受了RRT(48.5%),45例住院期间死亡(42.7%);②尿L-FABP可以预测行机械通气及合并脓毒症AKI患者是否需要进行RRT,AUC分别为0.822和0.743(P <0.001);③尿L-FABP可以预测AKI患者住院病死率,当截断值为124.95 ng/mg·Cr,敏感性和特异性均较高.对未发生心衰、行机械通气、AKIN-2和3期的AKI患者,尿L-FABP预测其住院期间死亡准确性好,AUC分别为0.844、0.832、0.912和0.900(P <0.05).校正了年龄、性别、急性肾衰预后评分(ATN-ISS)后,尿L-FABP高于均值组的患者发生住院期间死亡的风险比低于均值组高1.24倍(HR 2.24,95%CI 1.50~3.09,P=0.02).结论 住院患者中AKI的发生率及死亡率高.尿L-FABP可以预测行机械通气、合并脓毒症的AKI患者是否需要RRT,以及AKI患者住院期间死亡率. Objective To observe the levels of urinary liver-type fatty acid-binding protein (L-FABP) in the in-hospital patients with acute kidney injury (AKI),and examine the performance of L-FABP for predicting renal replacement therapy (RRT) or in-hospital death.Methods This prospective cohort study contained 103 patients with an established diagnosis of AKI.The levels of serum creatinine,urine creatinine and urinary L-FABP were obtained at time of nephrology consultation.Receiver-operating characteristic curves were generated to explore the diagnostic performance of urinary L-FABP for predicting the outcomes of patients with AKI.Results ①Of 103 patients,50cases were under RRT (48.5%),45 cases died in hospital (42.7%).②L-FABP displayed better discrimination for prediction of RRT in patients with mechanical ventilation (AUC 0.822) and sepsis (AUC 0.743,P < 0.001).③ Urinary L-FABP performed well for prediction of in-hospital death,and sensitivity and specificity were high for a cut-off value of 124.95 ng/mg · Cr.L-FABP displayed better discrimination for prediction of in-hospital death in patients without heart failure (AUC 0.844),patients with mechanical ventilation (AUC 0.832),patients with stage-2 (AUC 0.912) and stage-3AKI (AUC 0.900,P < 0.05).After adjusted for age,gender and ATN-ISS,patients with urinary L-FABP above average would have a 1.24-fold higher probability of in-hospital death than those with urinary L-FABP below average (HR2.24,95%CI 1.50~3.09,P=0.02).Conclusion AKI is associated with increased morbidity and mortality in hospitalized patients.Urinary L-FABP performed well at predicting dialysis requirement for patients with mechanical ventilation and sepsis,and predicting in-hospital mortality for patients with AKI.
出处 《中国急救医学》 CAS CSCD 北大核心 2014年第6期528-533,I0003,共7页 Chinese Journal of Critical Care Medicine
关键词 急性肾损伤(AKI) 生物学标志物 肝脏型脂肪酸结合蛋白(L-FABP) 预后 Acute kidney injury(AKI) Biomarker Liver fatty acid-binding protein (L-FABP) Prognosis
  • 相关文献

参考文献25

  • 1Medve L, Antek C, Paloczi B, et al. Epidemiology in Hungarian intensive care units: a muhicenter, prospective, observational study[J]. BMC Nephrol, 2011, 12: 43.
  • 2Coca SG, Yusuf B, Shlipak MG, et al. Long - term risk of mor- tality and other adverse outcomes after acute kidney injury: a sys- tematic review and meta- analysis [ J ]. Am J Kidney Dis, 2009, 53(6) : 961 -973.
  • 3Bah'era -Chimal J, Bobadilla NA. Are recently reported biomarkers helpful for early and accurate diagnosis of acute kidney injury[ J]. Biomarkers, 2012, 17(5): 385-393.
  • 4Camou F, Oger S, Paroissin C, et al. Plasma neutrophil gelati- nase- associated lipocalin (NGAL) predicts acute kidney injury in septic shock at ICU admission [ J ]. Ann Fr Anesth Reanim, 2013, 32(3) : 157 -164.
  • 5Royakkers AA, Korevaar JC, van Suijlen JD, et al. Serum and urine cystatin C are poor biomarker for acute kidney injury and re- nal replacement therapy[ J]. Intensive Care Med, 2011, 37(3) : 493- 501.
  • 6Park MY, Choi SJ, Kim JK, et al. Urinary cystatin C levels as a diagnostic and prognostic biomarkcr in patients with acute kidney injury[J]. Nephrology (Carlton), 2013, 18(4): 256-262.
  • 7Seabra VF, Perianayagam MC, Tighiouart H, et al. Urinary α- GST and π- GST for prediction of dialysis requirement or in - hospital death in established acute kidney injury[ J]. Biomarkers, 2011, 16(8) : 709 -717.
  • 8McMahon BA, Murray PT. Urinary liver fatty acid - binding pro- tein : another novel biomarker of acute kidney injury [ J ]. Kidney Int, 2010, 77(8) : 657 -659.
  • 9Kamijo -Ikemori A, Sugaya T, Matsui K, et al. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL - FABP chromosomal transgenic mice [ J ]. Nephrology (Carlton), 2011, 16(6) : 539 -544.
  • 10Ferguson MA, Vaidya VS, Waikar SS, et al. Urinary liver - type fatty acid - binding protein predicts adverse outcomes in acute kidney injury[J]. Kidney Int, 2010, 77(8) : 708 -714.

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部